Empirical micafungin treatment doesn't improve survival

Empirical micafungin treatment doesn't improve survival

Empirical treatment with micafungin seems not to increase invasive fungal infection (IFI)-free survival at 28 days for patients with intensive care unit (ICU)-acquired sepsis with Candida colonization.... read more

FDA Warns About Hepatitis B Reactivation from Hepatitis C Antivirals

FDA Warns About Hepatitis B Reactivation from Hepatitis C Antivirals

The FDA issued a warning yesterday about the risk of hepatitis B virus becoming active again in patients with current or previous infection who received treatment with hepatitis C virus treatments.... read more

New HIV treatment appears to have fully erased the virus from a patient's blood

New HIV treatment appears to have fully erased the virus from a patient's blood

A pioneering new trial offers new hope in the fight against HIV after a patient treated with a new therapy appears to have no trace of the virus in their blood.... read more

New tool helps measure how costs of care impact cancer patients

New tool helps measure how costs of care impact cancer patients

For many patients, the uncertainty and stress that can come with cancer treatment is compounded by what is now known as "financial toxicity", the anxiety and distress that follow health care and medication expenses, often... read more

Use of Evidence-Based Medical Therapy Steadily Improving in Acute MI Patients Postdischarge

Use of Evidence-Based Medical Therapy Steadily Improving in Acute MI Patients Postdischarge

Over a recent 10-year period, there has been an improvement in the prescription of evidence-based medical therapy for patients who survive and are discharged from hospital after an MI, a new analysis shows.... read more

New Treatment Guidelines for Rare Lung Disease

New Treatment Guidelines for Rare Lung Disease

Clinical practice guidelines created for the treatment and diagnosis of lymphangioleiomyomatosis (LAM).... read more

Use of interventions improves patient care for viral hepatitis

Researchers recommend multiple, inexpensive interventions be included in screening, diagnosis and treatment programs for patients with hepatitis B and C viruses, in an effort to optimize the outcomes of hepatitis care.... read more

Gene could lead to ALS therapies

Gene could lead to ALS therapies

Researchers from Ben-Gurion University of the Negev say their new gene study could lead to new treatments for amyotrophic lateral sclerosis, or ALS.... read more

Should we treat pyrexia? And how do we do it?

Should we treat pyrexia? And how do we do it?

Pyrexia has long been thought of as a protective physiological response to help host defences, although this is now being challenged. Despite recent advances, it remains unclear whether pyrexia or the physiological response... read more

Increasing survival after admission to UK critical care units following cardiopulmonary resuscitation

Increasing survival after admission to UK critical care units following cardiopulmonary resuscitation

In recent years there have been many developments in post-resuscitation care. We have investigated trends in patient characteristics and outcome following admission to UK critical care units following cardiopulmonary resuscitation... read more

Gene therapy for LPLD patients linked to lower frequency and severity of pancreatitis

Gene therapy for LPLD patients linked to lower frequency and severity of pancreatitis

Up to 6 years after receiving a single treatment with the gene therapy product lipoprotein lipase (LPL), patients with the debilitating genetic disease LPL deficiency (LPLD) had about 50% fewer episodes of pancreatitis than... read more

HDAC inhibitors show promise against cancer stem cells

HDAC inhibitors show promise against cancer stem cells

A group of researchers, led by scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has shown that histone deacetylase (HDAC) inhibitors have the potential to eliminate... read more

FDA approves automated insulin delivery device for type 1 diabetes

FDA approves automated insulin delivery device for type 1 diabetes

The Food and Drug Administration (FDA) has approved a device that automatically monitors blood glucose levels and delivers insulin when appropriate, for people aged 14 years and older who have type 1 diabetes.... read more

Fear of stigma or sanction keeps many doctors from revealing mental health issues

Fear of stigma or sanction keeps many doctors from revealing mental health issues

Even as doctors across America encourage their patients to share concerns about depression, anxiety and other concerns, so they can get help from modern treatments, a new study suggests the doctors may be less likely to seek... read more